Secondary Logo

Journal Logo

CURRENT WORLD LITERATURE: Bibliography

Current World Literature

doi: 10.1097/WCO.0b013e32835cb4f9
  • Free

This bibliography is compiled by clinicians from the relevant journals scanned by this publication. It is based on the literature regularly pulled into our database from OvidSP (articles are generally added to the database about two and a half months after publication). In addition, the bibliography contains every paper annotated by reviewers; these references were obtained from a variety of bibliographic databases and published between the beginning of the review period and the time of going to press. The bibliography has been grouped into topics that relate to the reviews in this issue.

▪ Papers considered by the reviewers to be of special interest

▪▪ Papers considered by the reviewers to be of outstanding interest

The number in square brackets following a selected paper, e.g. [7], refers to its number in the annotated references of the corresponding review.

Cerebrovascular disease

Ischemic preconditioning and clinical scenarios

Review: (pp. 1–7)

Ahmed LA, Salem HA, Attia AS, Agha AM. Comparative study of the cardioprotective effects of local and remote preconditioning in ischemia/reperfusion injury. Life Sci 2012; 90:249–256.

Cai ZQP, Parajuli N, Zheng XX, Becker L. Remote ischemic preconditioning confers late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10 - art. no. 277. Basic Res Cardiol 2012; 107:277.

Coelho AMM, Machado MCC, Takahashi HK, Sampietre SN, et al. Ischemic Preconditioning-Like Effect of Polyunsaturated Fatty Acid-Rich Diet on Hepatic Ischemia/Reperfusion Injury. J Gastrointest Surg 2011; 15:1679–1688.

Gao CJ, Niu L, Ren PC, Wang W, et al. Hypoxic preconditioning attenuates global cerebral ischemic injury following asphyxial cardiac arrest through regulation of delta opioid receptor system. Neuroscience 2012; 202: 352–362.

Hausenloy DJ, Candilio L, Laing C, Kunst G, et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial. Clin Res Cardiol 2012; 101:339–348.

He YD, Karabiyikoglu M, Hua Y, Keep RF, et al. Ischemic Preconditioning Attenuates Brain Edema After Experimental Intracerebral Hemorrhage. Transl Stroke Res 2012; 3:S180–S187.

Hong DM, Jeon Y, Lee CS, Kim HJ, et al. Effects of Remote Ischemic Preconditioning With Postconditioning in Patients Undergoing Off-Pump Coronary Artery Bypass Surgery - Randomized Controlled Trial. Circ J 2012; 76:884–890.

Hu S, Dong HL, Zhang HP, Wang SQ, et al. Noninvasive limb remote ischemic preconditioning contributes neuroprotective effects via activation of adenosine A1 receptor and redox status after transient focal cerebral ischemia in rats. Brain Res 2012;1459:12.

▪. Koch S, Katsnelson M, Dong C, Perez-Pinzon M. Remote ischemic limb preconditioning after subarachnoid hemorrhage: a phase Ib study of safety and feasibility. Stroke 2011; 42:1387–1391. [67]

Kurian GA, Berenshtein E, Saada A, Chevion M. Rat Cardiac Mitochondrial Sub-populations Show Distinct Features of Oxidative Phosphorylation during Ischemia, Reperfusion and Ischemic Preconditioning. Cell Physiol Biochem 2012; 30:83–94.

Lee WY, Koh EJ, Lee SM. A combination of ischemic preconditioning and allopurinol protects against ischemic injury through a nitric oxide-dependent mechanism. Nitric Oxide-Biol Chem 2012; 26:1–8.

▪. Leung PY, Stevens SL, Packard AE, et al. Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism. Stroke 2012; 43:1383–1389. [40]

Liang J, Wang J, Saad Y, Warble L, et al. Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines - art. no. 182. J Neuroinflamm 2011; 8:24.

▪. Liu C, Peng Z, Zhang N, et al. Identification of differentially expressed microRNAs and their PKC-isoform specific gene network prediction during hypoxic preconditioning and focal cerebral ischemia of mice. J Neurochem 2012; 120:830–841. [53]

Lu Y, Dong CS, Yu JM, Li H. Morphine Reduces the Threshold of Remote Ischemic Preconditioning Against Myocardial Ischemia and Reperfusion Injury in Rats: The Role of Opioid Receptors. J Cardiothorac Vasc Anesth 2012; 26:403–406.

Mahfoudh-Boussaid A, Zaouali MA, Hadj-Ayed K, Miled AH, et al. Ischemic preconditioning reduces endoplasmic reticulum stress and upregulates hypoxia inducible factor-1 alpha in ischemic kidney: the role of nitric oxide - art. no. 7. J Biomed Sci 2011; 19:17.

Moro L, Pedone C, Mondi A, Nunziata E, et al. Effect of local and remote ischemic preconditioning on endothelial function in young people and healthy or hypertensive elderly people. Atherosclerosis 2011; 219:750–752.

▪▪. Morris KC, Lin HW, Thompson JW, Perez-Pinzon MA. Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning. J Cereb Blood Flow Metab 2011; 31:1003–1019. [18]

Packard AEB, Hedges JC, Bahjat FR, Stevens SL, et al. Poly-IC preconditioning protects against cerebral and renal ischemia-reperfusion injury. J Cereb Blood Flow Metab 2012; 32:242–247.

▪▪. Perez-Pinzon MA, Stetler RA, Fiskum G. Novel mitochondrial targets for neuroprotection. J Cereb Blood Flow Metab 2012; 32:1362–1376. [33]

Przyklenk K, Whittaker P. Remote Ischemic Preconditioning: Current Knowledge, Unresolved Questions, and Future Priorities. J Cardiovasc Pharmacol Ther 2011; 16:255–259.

▪. Sheng R, Liu XQ, Zhang LS, et al. Autophagy regulates endoplasmic reticulum stress in ischemic preconditioning. Autophagy 2012; 8:310–325. [62]

Sofia S, Melone A, Manzoli L, De Ciantis P, et al. Cardiovascular and Cerebrovascular Events Pre- and Post-Earthquake of 6 April 2009: The Abruzzo's Experience. Am J Hypertens 2012; 25:556–560.

Takahashi T, Steinberg GK, Zhao H. Phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 may not always represent its kinase activity in a rat model of focal cerebral ischemia with or without ischemic preconditioning. Neuroscience 2012; 209:155–160.

Wojtovich AP, Nadtochiy SM, Brookes PS, Nehrke K. Ischemic preconditioning: The role of mitochondria and aging. Exp Gerontol 2012; 47:1–7.

Xu T, Gong Z, Zhu WZ, Wang JF, et al. Remote ischemic preconditioning protects neurocognitive function of rats following cerebral hypoperfusion. Med Sci Monitor 2011; 17:BR299–BR304.

Young PJ, Dalley P, Garden A, Horrocks C, et al. A pilot study investigating the effects of remote ischemic preconditioning in high-risk cardiac surgery using a randomised controlled double-blind protocol - art. no. 256. Basic Res Cardiol 2012; 107:256.

Yung LM, Wei Y, Qin T, Wang YM, et al. Sphingosine Kinase 2 Mediates Cerebral Preconditioning and Protects the Mouse Brain Against Ischemic Injury. Stroke 2012; 43:199.

Hypertension: Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure guidelines

Review: (pp. 8–12)

▪▪. Bertoia ML, Waring ME, Gupta PS, et al. Implications of new hypertension guidelines in the United States. Hypertension 2012; 60:639–644. [30]

▪. Fryar CD, Chen T, Li X. Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999–2010. NCHS data brief. no. 103. Hyattsville, MD: National Center for Health Statistics; 2012. [38]

▪. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:227–276. [32]

▪. Handler J, Lackland DT. Translation of hypertension treatment guidelines into practice: a review of implementation. J Am Soc Hypertens 2011; 5:197–207. [29]

Jeon D, Chu K, Lee ST, Jung KH, et al. A cell-free extract from human adipose stem cells protects mice against epilepsy. Epilepsia 2011; 52:1617–1626.

▪▪. Lackland DT, Elkind MS, D'Agostino Sr R, et al. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012; 43:1998–2027. [31]

▪▪. Tomaselli GF, Harty MB, Horton K, Schoeberl M. The American Heart Association and the Million Hearts Initiative: a presidential advisory from the American Heart Association. Circulation 2011; 124:1795–1799. [40]

Umar S, Rabinovitch M, Eghbali M. Estrogen Paradox in Pulmonary Hypertension Current Controversies and Future Perspectives. Am J Respir Crit Care Med 2012; 186:125–131.

von Heesen M, Seibert K, Hulser M, Scheuer C, et al. Multidrug donor preconditioning protects steatotic liver grafts against ischemia-reperfusion injury. Am J Surg 2012; 203:168–176.

▪. Wright JD, Hughes JP, Ostchega Y. Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001–2008. National Health Statistics Reports; no. 35. Hyattsville, MD: National Center for Health Statistics; 2011. [11]

Shared associations of nonatherosclerotic, large-vessel, cerebrovascular arteriopathies: considering intracranial aneurysms, cervical artery dissection, moyamoya disease and fibromuscular dysplasia

Review: (pp. 13–28)

Abu Rahma AF, Srivastava M, Mousa AY, Dearing DD, et al. Critical analysis of renal duplex ultrasound parameters in detecting significant renal artery stenosis. J Vasc Surg 2012; 56:1052–1059.

▪. Algra AM, Klijn CJ, Helmerhorst FM, et al. Female risk factors for subarachnoid hemorrhage: a systematic review. Neurology 2012; 79:1230–1236. [64]

▪. Callaghan FM, Luechinger R, Kurtcuoglu V, et al. Wall stress of the cervical carotid artery in patients with carotid dissection: a case-control study. Am J Physiol Heart Circ Physiol 2011; 300:H1451–H1458. [96]

▪. Debette S. ‘Genetics of cervical artery dissection’. In: Sharma P, Meschia JF, editors. Stroke genetics. London: Springer-Verlag; 2013. pp. 207–221. [122]

▪. Debette S, Grond-Ginsbach C, Bodenant M, et al. Differential features of carotid and vertebral artery dissections: the CADISP study. Neurology 2011; 77:1174–1181. [93]

▪. Debette S, Metso T, Pezzini A, et al. Association of vascular risk factors with cervical artery dissection and ischemic stroke in young adults. Circulation 2011; 123:1537–1544. [99]

Dolak W, Maresch J, Kainberger F, Wrba F, et al. Fibromuscular dysplasia mimicking Crohn's disease over a period of 23 years. J Crohns Colitis 2012; 6:354–357.

Dursun B, Yagci B, Batmazoglu M, Demiray G. Bilateral renal infarctions complicating fibromuscular dysplasia of renal arteries in a young male. Scand J Urol Nephrol 2012; 46:73–77.

▪▪. Foroud T, Koller DL, Lai D, et al. Genome-wide association study of intracranial aneurysms confirms role of anril and SOX17 in disease risk. Stroke 2012; 43:2846–2852. [84]

Gordhan A. Onyx Embolization of High-Flow Spontaneous Cervical Vertebral Arteriovenous Fistula. Vasc Endovasc Surg 2012; 46:484–486.

▪. Grond-Ginsbach C, Chen B, Pjontek R, et al. Copy number variation in patients with cervical artery dissection. Eur J Hum Genet 2012; 20:1295–1299. [222]

Heran MKS, Sangha BS, White C. Renal hyperperfusion injury resulting in transient proteinuria post renal artery angioplasty for fibromuscular dysplasia. Pediatr Radiol 2012; 42:491–494.

▪. Houkin K, Ito M, Sugiyama T, et al. Review of past research and current concepts on the etiology of moyamoya disease. Neurol Med Chir 2012; 52:267–277. [124]

Hyun CL, Park HS, Shin HJ, Yoon SP. Hypoplasia of Left Vertebral Artery with Intimal Fibromuscular Dysplasia in a Korean Woman. J Korean Med Sci 2012; 27:811–813.

▪. Joo SP, Kim TS, Lee IK, et al. A genome-wide study of moyamoya-type cerebrovascular disease in the korean population. J Korean Neurosurg Soc 2011; 50:486–491. [221]

▪. Kamada F, Aoki Y, Narisawa A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 2011; 56:34–40. [130]

▪. Kloss M, Metso A, Pezzini A, et al. Towards understanding seasonal variability in cervical artery dissection (CeAD). J Neurol 2012; 259:1662–1667. [217]

▪. Koizumi A, Kobayashi H, Liu W, et al. P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure. Environ Health Prev Med 2012 [Epub ahead of print]. [145]

▪. Kraemer M, Horn PA, Roder C, et al. Analysis of human leucocyte antigen genes in Caucasian patients with idiopathic Moyamoya angiopathy. Acta Neurochir 2012; 154:445–454. [151]

▪. Krischek B, Kasuya H, Khan N, et al. Genetic and clinical characteristics of moyamoya disease in Europeans. Acta Neurochir Suppl 2011; 112:31–34. [131]

▪. Kwak JH, Choi JW, Park HJ, et al. Cerebral artery dissection: spectrum of clinical presentations related to angiographic findings. Neurointervention 2011; 6:78–83. [196]

Kwee TC, de Jong PA, Rutgers DR. A ruptured intracranial aneurysm with underlying cervicocranial fibromuscular dysplasia. Vasc Med 2012; 17:66–67.

▪. Larsson E, Labruto F, Gasser TC, et al. Analysis of aortic wall stress and rupture risk in patients with abdominal aortic aneurysm with a gender perspective. J Vasc Surg 2011; 54:295–299. [76]

Lee MS, Lluri G. Standing Waves Are Not Fibromuscular Dysplasia Reply. JACC-Cardiovasc Interv 2012; 5: 888–889.

Liu CH, Wu DA, Chin SC, Fu SC, et al. Cervicocranial Fibromuscular Dysplasia in Taiwanese Ischemic Stroke Patients. Eur Neurol 2012; 67:129–135.

▪. Liu W, Morito D, Takashima S, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PloS One 2011; 6:e22542. [146]

Lluri G, Provias T, Yang EH, Lee MS. Fibromuscular Dysplasia of the Left Anterior Descending Coronary Artery. JACC-Cardiovasc Interv 2012; 5:E11–E12.

▪. Metso AJ, Metso TM, Debette S, et al. Gender and cervical artery dissection. Eur J Neurol 2012; 19:594–602. [98]

▪. Miskinyte S, Butler MG, Herve D, et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet 2011; 88:718–728. [138]

▪. Miyatake S, Miyake N, Touho H, et al. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 2012; 78:803–810. [139]

▪. Moran C, Phan TG, Srikanth VK. Cerebral small vessel disease: a review of clinical, radiological, and histopathological phenotypes. Int J Stroke 2012; 7:36–46. [02]

Mousa AY, Campbell JE, Stone PA, Broce M, et al. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period. J Vasc Surg 2012; 55:421–427.

▪. Munot P, Saunders DE, Milewicz DM, et al. A novel distinctive cerebrovascular phenotype is associated with heterozygous Arg179 ACTA2 mutations. Brain 2012; 135:2506–2514. [45]

▪. Ohrlander T, Merlo J, Ohlsson H, et al. Socioeconomic position, comorbidity, and mortality in aortic aneurysms: a 13-year prospective cohort study. Ann Vasc Surg 2012; 26:312–321. [213]

▪. Olin JW, Froehlich J, Gu X, et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation 2012; 125:3182–3190. [156]

Olin JW, Froehlich J, Gu XK, Bacharach JM, et al. The United States Registry for Fibromuscular Dysplasia Results in the First 447 Patients. Circulation 2012; 125:3182.

Olin JW, Gornik HL. Standing Waves Are Not Fibromuscular Dysplasia. JACC-Cardiovasc Interv 2012; 5:888.

Persu A, Touze E, Mousseaux E, Barral X, et al. Diagnosis and management of fibromuscular dysplasia: an expert consensus. Eur J Clin Invest 2012; 42:338–347.

▪. Pezzini A, Drera B, Del Zotto E, et al. Mutations in TGFBR2 gene cause spontaneous cervical artery dissection. J Neurol Neurosurg Psychiatry 2011; 82:1372–1374. [121]

▪. Poloskey SL, Kim ES, Sanghani R, et al. Low yield of genetic testing for known vascular connective tissue disorders in patients with fibromuscular dysplasia. Vasc Med 2012 [Epub ahead of print]. [169]

Poloskey SL, Olin JW, Mace P, Gornik HL. Fibromuscular Dysplasia. Circulation 2012; 125:E636–E639.

Rastogi N, Kabutey NK, Kim D, Farber A. Symptomatic Fibromuscular Dysplasia of the External Iliac Artery - art. no. 574.e9. Ann Vasc Surg 2012; 26:E9.

▪. Regalado ES, Guo DC, Villamizar C, et al. Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms. Circ Res 2011; 109:680–686. [14]

Saw J, Poulter R, Fung A, Wood D, et al. Spontaneous Coronary Artery Dissection in Patients With Fibromuscular Dysplasia A Case Series. Circ-Cardiovasc Interv 2012; 5:134–137.

▪. Schievink WI, Debette S. Etiology of cervical artery dissections: the writing is in the wall. Neurology 2011; 76:1452–1453. [95]

Schwartz C, Kamper L, Haage P. Unusual Combination of fibromuscular Dysplasia of Localizations. Rofo-Fortschr Gebiet Rontgenstrahlen Bildgeb Verfahr 2011; 183: 1164.

Sharma AM, Gornik HL. Standing Arterial Waves Is NOT Fibromuscular Dysplasia. Circ-Cardiovasc Interv 2012; 5:E9–E11.

Tan WH, Egyhazi R, Isaac Z. C6 Radiculopathy: The Initial Presentation of Fibromuscular Dysplasia. Pm&R 2012; 4:527–529.

▪. van de Laar IM, van der Linde D, Oei EH, et al. Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet 2012; 49:47–57. [15]

▪. Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 2011; 10:626–636. [61]

▪. Volker W, Dittrich R, Grewe S, et al. The outer arterial wall layers are primarily affected in spontaneous cervical artery dissection. Neurology 2011; 76:1463–1471. [113]

▪. Volonghi I, Frigerio M, Mardighian D, et al. Grange syndrome: an identifiable cause of stroke in young adults. Am J Med Genet Part A 2012; 158A:2894–2898. [29]

▪. Weinberg DG, Arnaout OM, Rahme RJ, et al. Moyamoya disease: a review of histopathology, biochemistry, and genetics. Neurosurg Focus 2011; 30:E20. [136]

▪. Weng YC, Sonni A, Labelle-Dumais C, et al. COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage. Ann Neurol 2012; 71:470–477. [37]

▪. Xin B, Jones S, Puffenberger EG, et al. Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke. Proc Natl Acad Sci U S A 2011; 108:5372–5377. [40]

Vascular cognitive impairment

Review: (pp. 29–36)

▪. Brookmeyer R, Evans DA, Hebert L, et al. National estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement 2011; 7:61–73. [02]

Deramecourt V, Slade JY, Oakley AE, Perry RH, et al. Staging and natural history of cerebrovascular pathology in dementia. Neurology 2012; 78:1043–1050.

Gommer ED, Martens E, Aalten P, Shijaku E, et al. Dynamic Cerebral Autoregulation in Subjects with Alzheimer's Disease, Mild Cognitive Impairment, and Controls: Evidence for Increased Peripheral Vascular Resistance with Possible Predictive Value. J Alzheimers Dis 2012; 30:805–813.

▪▪. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:2672–2713. [10]

Li CC, Zheng Y, Wang XY, Xia W, et al. Bone Marrow-Derived Stem Cells Contribute Skin Regeneration in Skin and Soft Tissue Expansion. J Cell Physiol 2011; 226:2834–2840.

Moser DJ, Ponto LLB, Miller IN, Schultz SK, et al. Cerebral blood flow and neuropsychological functioning in elderly vascular disease patients. J Clin Exp Neuropsychol 2012; 34:220–225.

▪▪. Rusanen M, Kivipelto M, Quesenberry Jr CP, et al. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med 2011; 171:333–339. [79]

▪. Schipper HM. Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment. Neurobiol Aging 2011; 32:778–790. [65]

Smallwood A, Oulhaj A, Joachim C, Christie S, et al. Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort. Neuropathol Appl Neurobiol 2012; 38:337–343.

Sofia S, Melone A, Manzoli L, De Ciantis P, et al. Cardiovascular and Cerebrovascular Events Pre- and Post-Earthquake of 6 April 2009: The Abruzzo's Experience. Am J Hypertens 2012; 25:556–560.

Umar S, Rabinovitch M, Eghbali M. Estrogen Paradox in Pulmonary Hypertension Current Controversies and Future Perspectives. Am J Respir Crit Care Med 2012; 186:125–131.

▪▪. Vieira JR, Elkind MS, Moon YP, et al. The metabolic syndrome and cognitive performance: the northern Manhattan study. Neuroepidemiology 2011; 37:153–159. [74]

von Heesen M, Seibert K, Hulser M, Scheuer C, et al. Multidrug donor preconditioning protects steatotic liver grafts against ischemia-reperfusion injury. Am J Surg 2012; 203:168–176.

Promoting neuroplasticity and recovery after stroke: future directions for rehabilitation clinical trials

Review: (pp. 37–42)

Arboix A. Intrahospitalary stroke: hidden side of acute cerebrovascular disease. Med Clin 2011; 137:495–496.

Baxi NS, Jackson JL, Ritter J, Sessums LL. How Well do the Framingham Risk Factors Correlate With Diagnoses of Ischemic Heart Disease and Cerebrovascular Disease in a Military Beneficiary Cohort? Milit Med 2011; 176:408–413.

▪. Bolognini N, Vallar G, Casati C, et al. Neurophysiological and behavioral effects of tDCS combined with constraint-induced movement therapy in poststroke patients. Neurorehabil Neural Repair 2011; 25:819–829. [45]

▪▪. Duncan PW, Sullivan KJ, Behrman AL, et al. Body-weight-supported treadmill rehabilitation after stroke. N Engl J Med 2011; 364:2026–2036. [05]

Garg S, Sarno G, Gutierrez-Chico JL, Garcia-Garcia HM, et al. Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study. EuroIntervention 2011; 6:1060–1067.

▪. Hornby TG, Straube DS, Kinnaird CR, et al. Importance of specificity, amount, and intensity of locomotor training to improve ambulatory function in patients poststroke. Topics Stroke Rehabil 2011; 18:293–307. [16]

Ito H, Nussbaum M, Hermiller JB, Hodes Z, et al. An integer based risk score for predicting 30-day major adverse cardiac or cerebrovascular events after percutaneous coronary intervention with drug-eluting stents: results from a large prospective multicentre registry, the STENT Group. EuroIntervention 2011; 6:942–948.

Kaffashian S, Dugravot A, Nabi H, Batty GD, et al. Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II study. Eur Heart J 2011; 32:2326–2332.

Kuwabara K, Matsuda S, Fushimi K, Ishikawa KB, et al. Reconsidering the value of rehabilitation for patients with cerebrovascular disease in Japanese acute health care hospitals. Value Health 2011; 14:166–176.

▪. Nair DG, Renga V, Lindenberg R, et al. Optimizing recovery potential through simultaneous occupational therapy and noninvasive brain-stimulation using tDCS. Restorative Neurol Neurosci 2011; 29:411–420. [44]

Steindler DA, Okun MS, Scheffler B. Stem cell pathologies and neurological disease. Mod Pathol 2012; 25:157–162.

Intracerebral Hemorrhage

Cowart JB, Taylor AA. Should Two-Drug Initial Therapy for Hypertension Be Recommended for All Patients? Curr Hypertens Rep 2012; 14:324–332.

MacLellan CL, Paquette R, Colbourne F. A critical appraisal of experimental intracerebral hemorrhage research. J Cereb Blood Flow Metab 2012; 32:612–627.

Wang ZZ, Cui C, Li QL, Zhou SX, et al. Intracerebral transplantation of foetal neural stem cells improves brain dysfunction induced by intracerebral haemorrhage stroke in mice. J Cell Mol Med 2011; 15:2624–2633.

Stroke genetics

Gaul C, Gerloff C. Idiopathic Intracranial Hypertension. Aktuelle Neurol 2012; 39:186–191.

Holtz JE, Upadhyaya DS, Cohen BE, Na B, et al. Mitral Annular Calcium, Inducible Myocardial Ischemia, and Cardiovascular Events in Outpatients With Coronary Heart Disease (from the Heart and Soul Study). Am J Cardiol 2012; 109:1092–1096.

Stem Cells in Stroke

Abe K, Yamashita T, Takizawa S, Kuroda S, et al. Stem cell therapy for cerebral ischemia: from basic science to clinical applications. J Cereb Blood Flow Metab 2012; 32:1317–1331.

Alasheev AM, Belkin AA, Leiderman IN, Ivanov RA, et al. Granulocyte-colony-stimulating Factor for Acute Ischemic Stroke: A Randomized Controlled Trial (STEMTHER). Transl Stroke Res 2011; 2:358–365.

Andres RH, Choi R, Pendharkar AV, Gaeta X, et al. The CCR2/CCL2 Interaction Mediates the Transendothelial Recruitment of Intravascularly Delivered Neural Stem Cells to the Ischemic Brain. Stroke 2011; 42:2923.

Arien-Zakay H, Lecht S, Nagler A, Lazarovici P. Neuroprotection by human umbilical cord blood-derived progenitors in ischemic brain injuries. Arch Ital Biol 2011; 149:233–245.

Auriat AM, Rosenblum S, Smith TN, Guzman R. Intravascular Stem Cell Transplantation for Stroke. Transl Stroke Res 2011; 2:250–265.

Bible E, Dell'Acqua F, Solanky B, Balducci A, et al. Non-invasive imaging of transplanted human neural stem cells and ECM scaffold remodeling in the stroke-damaged rat brain by F-19- and diffusion-MRI. Biomaterials 2012; 33:2858–2871.

Boltze J, Nitzsche B, Geiger KD, Schoon HA. Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model. Transl Stroke Res 2011; 2:279–293.

Boltze J, Reich DM, Hau S, Reymann KG, et al. Assessment of Neuroprotective Effects of Human Umbilical Cord Blood Mononuclear Cell Subpopulations In Vitro and In Vivo. Cell Transplant 2012; 21:723–737.

Borlongan CV. Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all!. Leukemia 2011; 25:1674–1686.

Borlongan CV, Glover LE, Tajiri N, Kaneko Y, et al. The great migration of bone marrow-derived stem cells toward the ischemic brain: Therapeutic implications for stroke and other neurological disorders. Prog Neurobiol 2011; 95:213–228.

Brandner S, Kleindienst A. Neuroprotection and neuroregeneration: What to expect from a stem cell-based therapy of acute brain injury. Crit Care Med 2011; 39:2577–2578.

Cho YJ, Song HS, Bhang S, Lee S, et al. Therapeutic effects of human adipose stem cell-conditioned medium on stroke. J Neurosci Res 2012; 90:1794–1802.

Cossetti C, Alfaro-Cervello C, Donega M, Tyzack G, et al. New perspectives of tissue remodelling with neural stem and progenitor cell-based therapies. Cell Tissue Res 2012; 349:321–329.

Cui X, Chopp M, Shehadah A, Zacharek A, et al. Therapeutic Benefit of Treatment of Stroke With Simvastatin and Human Umbilical Cord Blood Cells: Neurogenesis, Synaptic Plasticity, and Axon Growth. Cell Transplant 2012; 21:845–856.

Cui Y, Madeddu P. The Role of Chemokines, Cytokines and Adhesion Molecules in Stem Cell Trafficking and Homing. Curr Pharm Design 2011; 17:3271–3279.

Cunningham LA, Cande lario K, Li L. Roles for HIF-1 alpha in neural stem cell function and the regenerative response to stroke. Behav Brain Res 2012; 227:410–417.

Danilov AI, Kokaia Z, Lindvall O. Ectopic ependymal cells in striatum accompany neurogenesis in a rat model of stroke. Neuroscience 2012; 214:159–170.

Doeppner TR, Ewert TAS, Tonges L, Herz J, et al. Transduction of Neural Precursor Cells with TAT-Heat Shock Protein 70 Chaperone: Therapeutic Potential Against Ischemic Stroke after Intrastriatal and Systemic Transplantation. Stem Cells 2012; 30:1297–1310.

England TJ, Abaei M, Auer DP, Lowe J, et al. Granulocyte-Colony Stimulating Factor for Mobilizing Bone Marrow Stem Cells in Subacute Stroke The Stem Cell Trial of Recovery Enhancement After Stroke 2 Randomized Controlled Trial. Stroke 2012; 43:405–411.

Franco ECS, Cardoso MM, Gouveia A, Pereira A, et al. Modulation of microglial activation enhances neuroprotection and functional recovery derived from bone marrow mononuclear cell transplantation after cortical ischemia. Neurosci Res 2012; 73:122–132.

Friedrich MAG, Martins MP, Araujo MD, Klamt C, et al. Intra-Arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Patients With Moderate to Severe Middle Cerebral Artery Acute Ischemic Stroke. Cell Transplant 2012; 21:S13–S21.

Fujimoto M, Hayashi H, Takagi Y, Hayase M, et al. Transplantation of telencephalic neural progenitors induced from embryonic stem cells into subacute phase of focal cerebral ischemia. Lab Invest 2012; 92:522–531.

Glover LE, Tajiri N, Weinbren NL, Ishikawa H, et al. A Step-up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem Cells. Transl Stroke Res 2012; 3:90–98.

Gomi M, Takagi Y, Morizane A, Doi D, et al. Functional recovery of the murine brain ischemia model using human induced pluripotent stem cell-derived telencephalic progenitors. Brain Res 2012;1459:12.

Gopurappilly R, Pal R, Mamidi MK, Dey S, et al. Stem Cells in Stroke Repair: Current Success & Future Prospects. CNS Neurol Disord-Drug Targets 2011; 10:741–756.

Hattori H, Suzuki S, Okazaki Y, Suzuki N, et al. Intracranial Transplantation of Monocyte-Derived Multipotential Cells Enhances Recovery After Ischemic Stroke in Rats. J Neurosci Res 2012; 90:479–488.

Hermann DM, Chopp M. Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol 2012; 11:369–380.

Honmou O, Onodera R, Sasaki M, Waxman SG, et al. Mesenchymal stem cells: therapeutic outlook for stroke. Trends Mol Med 2012; 18:292–297.

Jahromi GP, Seidi S, Sadr SS, Shabanzadeh AP, et al. Therapeutic Effects of a Combinatorial Treatment of Simvastatin and Bone Marrow Stromal Cells on Experimental Embolic Stroke. Basic Clin Pharmacol Toxicol 2012; 110:487–493.

Kanhai DA, Kappelle LJ, van der Graaf Y, Uiterwaal C, et al. The risk of general and abdominal adiposity in the occurrence of new vascular events and mortality in patients with various manifestations of vascular disease. Int J Obes 2012; 36:695–702.

Kokaia Z, Darsalia V. Neural Stem Cell-Based Therapy for Ischemic Stroke. Transl Stroke Res 2011; 2:272–278.

Li CC, Zheng Y, Wang XY, Xia W, et al. Bone Marrow-Derived Stem Cells Contribute Skin Regeneration in Skin and Soft Tissue Expansion. J Cell Physiol 2011; 226:2834–2840.

Lundberg J, Sodersten E, Sundstrom E, Le Blanc K, et al. Targeted Intra-arterial Transplantation of Stem Cells to the Injured CNS Is More Effective Than Intravenous Administration: Engraftment Is Dependent on Cell Type and Adhesion Molecule Expression. Cell Transplant 2012; 21:333–343.

Miller RH, Bai LH. Translating stem cell therapies to the clinic. Neurosci Lett 2012; 519:87–92.

Misra V, Lal A, El Khoury R, Chen PR, et al. Intra-Arterial Delivery of Cell Therapies for Stroke. Stem Cells Dev 2012; 21:1007–1015.

Mitrecic D. Current Advances in Intravascular Administration of Stem Cells for Neurological Diseases: A New Dose of Rejuvenation Injected. Rejuv Res 2011; 14:553–555.

Moon SU, Kim J, Bokara KK, Kim JY, et al. Carbon nanotubes impregnated with subventricular zone neural progenitor cells promotes recovery from stroke. Int J Nanomed 2012;2751; 7:2751-2765.

Muir KW, Sinden J, Miljan E, Dunn L. Intracranial Delivery of Stem Cells. Transl Stroke Res 2011; 2:266–271.

Nakagomi T, Molnar Z, Nakano-Doi A, Taguchi A, et al. Ischemia-Induced Neural Stem/Progenitor Cells in the Pia Mater Following Cortical Infarction. Stem Cells Dev 2011; 20:2037–2051.

Nih LR, Deroide N, Lere-Dean C, Lerouet D, et al. Neuroblast survival depends on mature vascular network formation after mouse stroke: role of endothelial and smooth muscle progenitor cell co-administration. Eur J Neurosci 2012; 35:1208–1217.

Oki K, Tatarishvili J, Wood J, Koch P, et al. Human-Induced Pluripotent Stem Cells form Functional Neurons and Improve Recovery After Grafting in Stroke-Damaged Brain. Stem Cells 2012; 30:1120–1133.

Qureshi IA, Mehler MF. Chromatin-Modifying Agents for Epigenetic Reprogramming and Endogenous Neural Stem Cell-Mediated Repair in Stroke. Transl Stroke Res 2011; 2:7–16.

Ramos-Cabrer P, Hoehn M. MRI Stem Cell Tracking for Therapy in Experimental Cerebral Ischemia. Transl Stroke Res 2012; 3:22–35.

Rodrigues MCO, Voltarelli J, Sanberg PR, Allickson JG, et al. Recent progress in cell therapy for basal ganglia disorders with emphasis on menstrual blood transplantation in stroke. Neurosci Biobehav Rev 2012; 36:177–190.

Rosenblum S, Wang N, Smith TN, Pendharkar AV, et al. Timing of Intra-Arterial Neural Stem Cell Transplantation After Hypoxia-Ischemia Influences Cell Engraftment, Survival, and Differentiation. Stroke 2012; 43:1624.

Rueger MA, Muesken S, Walberer M, Jantzen SU, et al. Effects of minocycline on endogenous neural stem cells after experimental stroke. Neuroscience 2012; 215:174–183.

Savitz SI. Stem cells and stroke: are we further away than anyone is willing to admit? Int J Stroke 2012; 7:34–35.

Selvaraj V, Jiang P, Chechneva O, Lo UG, et al. Differentiating human stem cells into neurons and glial cells for neural repair. Front Biosci 2012; 17:65–89.

Shimada IS, Le Comte MD, Granger JC, Quinlan NJ, et al. Self-Renewal and Differentiation of Reactive Astrocyte-Derived Neural Stem/Progenitor Cells Isolated from the Cortical Peri-Infarct Area after Stroke. J Neurosci 2012; 32:7926–7940.

Sinden JD, Muir KW. Stem cells in stroke treatment: the promise and the challenges. Int J Stroke 2012; 7:426–434.

Smith EJ, Stroemer RP, Gorenkova N, Nakajima M, et al. Implantation Site and Lesion Topology Determine Efficacy of a Human Neural Stem Cell Line in a Rat Model of Chronic Stroke. Stem Cells 2012; 30:785–796.

Smith HK, Gavins FNE. The potential of stem cell therapy for stroke: is PISCES the sign? Faseb J 2012; 26:2239–2252.

Steiner B, Roch M, Holtkamp N, Kurtz A. Systemically administered human bone marrow-derived mesenchymal stem home into peripheral organs but do not induce neuroprotective effects in the MCAo-mouse model for cerebral ischemia. Neurosci Lett 2012; 513:25–30.

Takata M, Nakagomi T, Kashiwamura S, Nakano-Doi A, et al. Glucocorticoid-induced TNF receptor-triggered T cells are key modulators for survival/death of neural stem/progenitor cells induced by ischemic stroke. Cell Death Differ 2012; 19:756–767.

Tsai LK, Wang ZF, Munasinghe J, Leng Y, et al. Mesenchymal Stem Cells Primed With Valproate and Lithium Robustly Migrate to Infarcted Regions and Facilitate Recovery in a Stroke Model. Stroke 2011; 42:2932.

van Velthoven CTJ, Kavelaars A, Heijnen CJ. Mesenchymal stem cells as a treatment for neonatal ischemic brain damage. Pediatr Res 2012; 71:474–481.

van Velthoven CTJ, van de Looij Y, Kavelaars A, Zijlstra J, et al. Mesenchymal stem cells restore cortical rewiring after neonatal ischemia in mice. Ann Neurol 2012; 71:785–796.

Voulgari-Kokota A, Fairless R, Karamita M, Kyrargyri V, et al. Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function. Exp Neurol 2012; 236:161–170.

Wang YF, Cooke MJ, Morshead CM, Shoichet MS. Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury. Biomaterials 2012; 33:2681–2692.

Wang ZL, Andrade N, Torp M, Wattananie S, et al. Meteorin is a chemokinetic factor in neuroblast migration and promotes stroke-induced striatal neurogenesis. J Cereb Blood Flow Metab 2012; 32:387–398.

Wang ZZ, Cui C, Li QL, Zhou SX, et al. Intracerebral transplantation of foetal neural stem cells improves brain dysfunction induced by intracerebral haemorrhage stroke in mice. J Cell Mol Med 2011; 15:2624–2633.

Yarygin KN, Yarygin VN. Neurogenesis in the central nervous system and prospects of regenerative neurology. Z Nevrol Psikhiatrii Im S S Korsakova 2012;Korsakova. 112:4-13.

Yu XL, Chen DP, Zhang Y, Wu XL, et al. Overexpression of CXCR4 in mesenchymal stem cells promotes migration, neuroprotection and angiogenesis in a rat model of stroke. J Neurol Sci 2012; 316:141–149.

Neuro-ophthalmology and neuro-otology

Intrinsically photosensitive retinal ganglion cells: classification, function and clinical implications

Review: (pp. 45–51)

Blasic JR, Brown RL, Robinson PR. Light-dependent phosphorylation of the carboxy tail of mouse melanopsin. Cell Mol Life Sci 2012; 69:1551–1562.

▪▪. Brown TM, Tsujimura S, Allen AE, et al. Melanopsin-based brightness discrimination in mice and humans. Curr Biol 2012; 22:1134–1141. [10]

▪▪. Chen SK, Badea TC, Hattar S. Photoentrainment and pupillary light reflex are mediated by distinct populations of ipRGCs. Nature 2011; 476:92–95. [28]

Feigl B, Zele AJ, Fader SM, Howes AN, et al. The post-illumination pupil response of melanopsin-expressing intrinsically photosensitive retinal ganglion cells in diabetes. Acta Ophthalmol 2012; 90:e230–e234.

Gonzalez-Menendez I, Contreras F, Garcia-Fernandez JM, Cernuda-Cernuda R. Perinatal development of melanopsin expression in the mouse retina. Brain Res 2012; 1419:24.

▪. Kankipati L, Girkin CA, Gamlin PD. The postillumination pupil response is reduced in glaucoma patients. Invest Ophthalmol Vis Sci 2011; 52:2287–2292. [55]

▪. Kardon R, Anderson SC, Damarjian TG, et al. Chromatic pupillometry in patients with retinitis pigmentosa. Ophthalmology 2011; 118:376–381. [42]

▪. Münch M, Léon L, Crippa SV, Kawasaki A. Circadian and wake-dependent effects on the pupil light reflex in response to narrow-bandwidth light pulses. Invest Ophthalmol Vis Sci 2012; 53:4546–4555. [52]

▪. Park JC, Moura AL, Raza AS, et al. Toward a clinical protocol for assessing rod, cone, and melanopsin contributions to the human pupil response. Invest Ophthalmol Vis Sci 2011; 52:6624–6635. [43]

Pulido C, Malagon G, Ferrer C, Chen JK, et al. The light-sensitive conductance of melanopsin-expressing Joseph and Hesse cells in amphioxus. J Gen Physiol 2012; 139:19–30.

▪▪. Sand A, Schmidt TM, Kofuji P. Diverese types of ganglion cell photoreceptors in the mammalian retina. Prog Retin Eye Res 2012; 31:287–302. [16]

▪. Wirz-Justice A, Terman M. Chronotherapeutics (light and wake therapy) as a class of interventions for affective disorders. Handb Clin Neurol 2012; 106:697–713. [82]

▪. Zele AJ, Feigl B, Smith SS, Markwell EL. The circadian response of intrinsically photosensitive retinal ganglion cells. PLoS One 2011; 6:e17860. [53]

Mitochondrial dysfunction in optic neuropathies: animal models and therapeutic options

Review: (pp. 52–58)

Amaral-Fernandes MS, Marcondes AM, Miranda P, Maciel-Guerra AT, et al. Mutations for Leber hereditary optic neuropathy in patients with alcohol and tobacco optic neuropathy. Mol Vis 2011; 17:3175–3179.

▪▪. Barboni P, Valentino ML, La Morgia C, et al. Idebenone treatment in OPA1-mutant dominant optic atrophy patients. Brain (in press). [57]

▪▪. Bouaita A, Augustin S, Lechauve C, et al. Downregulation of apoptosis-inducing factor in Harlequin mice induces progressive and severe optic atrophy which is durably prevented by AAV2-AIF1 gene therapy. Brain 2012; 135:35–52. [36]

▪▪. Carelli V, La Morgia C, Valentino ML, et al. Idebenone treatment in Leber's hereditary optic neuropathy. Brain 2011; 134:e188. [48]

Desir J, Coppieters F, van Regemorter N, De Baere E, et al. TMEM126A mutation in a Moroccan family with autosomal recessive optic atrophy. Mol Vis 2012; 18:1849–1857.

Enns GM, Kinsman SL, Perlman SL, Spicer KM, et al. Initial experience in the treatment of inherited mitochondrial disease with EPI-743. Mol Genet Metab 2012; 105:91–102.

▪▪. Giordano C, Montopoli M, Perli E, et al. Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. Brain 2011; 134:220–234. [66]

▪▪. Iyer S, Bergquist K, Young K, et al. Mitochondrial gene therapy improves respiration, biogenesis, and transcription in G11778A Leber's hereditary optic neuropathy and T8993G Leigh's syndrome cells. Hum Gene Ther 2012; 23:647–657. [29]

Ji FY, Sharpley MS, Derbeneva O, Alves LS, et al. Mitochondrial DNA variant associated with Leber hereditary optic neuropathy and high-altitude Tibetans. Proc Natl Acad Sci U S A 2012; 109:7391–7396.

▪▪. Klopstock T, Yu-Wai-Man P, Dimitriadis K, et al. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy. Brain 2011; 134:2677–2686. [47]

Leo-Kottler B, Wissinger B. Leber's hereditary optic neuropathy. Ophthalmologe 2011; 108:1179–1192.

▪▪. Lin CS, Sharpley MS, Fan W, et al. Mouse mtDNA mutant model of Leber hereditary optic neuropathy. Proc Natl Acad Sci USA 2012. [Epub ahead of print] [34]

McArthur JR, Singh G, McMaster D, Winkfein R, et al. Interactions of Key Charged Residues Contributing to Selective Block of Neuronal Sodium Channels by mu-Conotoxin KIIIA. Mol Pharmacol 2011; 80:573–584.

▪. Nakada K, Hayashi J. Transmitochondrial mice as models for mitochondrial DNA-based diseases. Exp Anim 2011; 60:421–431. [15]

Qian YP, Zhou XT, Liang M, Qu J, et al. The altered activity of complex III may contribute to the high penetrance of Leber's hereditary optic neuropathy in a Chinese family carrying the ND4 G11778A mutation. Mitochondrion 2011; 11:871–877.

Rinalduzzi S, Cipriani AM, Accornero N. Topiramate and visual loss in a patient carrying a Leber hereditary optic neuropathy mutation. Neurol Sci 2012; 33:419–421.

Schaaf CP, Blazo M, Lewis RA, Tonini RE, et al. Early-onset severe neuromuscular phenotype associated with compound heterozygosity for OPA1 mutations. Mol Genet Metab 2011; 103:383–387.

▪. Williams PA, Morgan JE, Votruba M. Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy. Brain 2010; 133:2942–2951. [10]

▪. Williams PA, Morgan JE, Votruba M. Mouse models of dominant optic atrophy: what do they tell us about the pathophysiology of visual loss? Vision Res 2011; 51:229–234. [05]

▪. Williams PA, Piechota M, von Ruhland C, et al. Opa1is essential for retinal ganglion cell synaptic architecture and connectivity. Brain 2012; 135:493–505. [11]

Ylikallio E, Suomalainen A. Mechanisms of mitochondrial diseases. Ann Med 2012; 44:41–59.

▪▪. Yu H, Koilkonda RD, Chou TH, et al. Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber's hereditary optic neuropathy in a mouse model. Proc Natl Acad Sci U S A 2012; 109:E1238–E1247. [30]

Yu H, Koilkonda RD, Chou TH, Porciatti V, et al. Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber's hereditary optic neuropathy in a mouse model. Proc Natl Acad Sci U S A 2012; 109:E1238–E1247.

Yu H, Ozdemir SS, Koilkonda RD, Chou TH, et al. Mutant NADH dehydrogenase subunit 4 gene delivery to mitochondria by targeting sequence- modified adeno-associated virus induces visual loss and optic atrophy in mice. Mol Vis 2012; 18:1668–1683.

Zhang L, Zhao HP, Blagg BSJ, Dobrowsky RT. C-Terminal Heat Shock Protein 90 Inhibitor Decreases Hyperglycemia-induced Oxidative Stress and Improves Mitochondrial Bioenergetics in Sensory Neurons. J Proteome Res 2012; 11:2581–2593.

Saccadic intrusions: review and update

Review: (pp. 59–66)

Ahlskog MC, Kumar N, Mauermann ML, Klein CJ. IgM-monoclonal gammopathy neuropathy and tremor: A first epidemiologic case control study. Parkinsonism Relat Disord 2012; 18:748–752.

▪. Blumkin L, Kivity S, Lev D, et al. A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus-myoclonus ataxia-like syndrome. J Neurol 2012 [Epub ahead of print]. [84]

▪. Brodsky MC, Hunter JS. Positional ocular flutter and thickened optic nerves as sentinel signs of Krabbe disease. J AAPOS 2011; 15:595–597. [12]

▪▪. Brunklaus A, Pohl K, Zuberi SM, et al. Outcome and prognostic features in opsoclonus-myoclonus syndrome from infancy to adult life. Pediatrics 2011; 128:e388–e394. [71]

Chandran V, Pal PK. Essential tremor: Beyond the motor features. Parkinsonism Relat Disord 2012; 18:407–413.

▪. Clausi S, De Luca M, Chiricozzi FR, et al. Oculomotor deficits affect neuropsychological performance in oculomotor apraxia type 2. Cortex 2012 [Epub ahead of print]. [25]

Coria F, Gimenez-Garcia M, Samaranch L, Mora FJ, et al. Nigrostriatal dopaminergic function in subjects with isolated action tremor. Parkinsonism Relat Disord 2012; 18:49–53.

▪. Fernandes TD, Bazan R, Betting LE, et al. Topiramate effect in opsoclonus-myoclonus-ataxia syndrome. Arch Neurol 2012; 69:133. [87]

▪▪. Gitchel GT, Wetzel PA, Baron MS. Pervasive ocular tremor in patients with Parkinson disease. Arch Neurol 2012; 69:1011–1017. [09]

▪. Groiss SJ, Siebler M, Schnitzler A. Full recovery of adult onset opsoclonus myoclonus syndrome after early immunotherapy: a case report. Mov Disord 2011; 26:1805–1807. [98]

▪▪. Hafed ZM. Mechanisms for generating and compensating for the smallest possible saccades. Eur J Neurosci 2011; 33:2101–2113. [35]

▪. Hage Jr R, Merle H, Jeannin S, et al. Ocular oscillations in the neuromyelitis optica spectrum. J Neuroophthalmol 2011; 31:255–259. [56]

▪▪. Iizuka T, Leite MI, Lang B, et al. Glycine receptor antibodies are detected in progressive encephalomyelitis with rigidity and myoclonus (PERM) but not in saccadic oscillations. J Neurol 2012; 259:1566–1573. [79]

Kumar N, Eggers SDZ, Milone M, Keegan BM. Acquired progressive ataxia and palatal tremor: Importance of MRI evidence of hemosiderin deposition and vascular malformations. Parkinsonism Relat Disord 2011; 17:565–568.

Liang H, Zheng W, Xu HB, Lei J, et al. No evidence of association between the LINGO4 gene and essential tremor in Chinese Han patients. Parkinsonism Relat Disord 2012; 18:303–305.

▪. Newey CR, Sarwal A, Wu G. Radiological correlate of ocular flutter in a case with paraneoplastic encephalitis. J Neuroimaging 2011 [Epub ahead of print]. [83]

▪. Nunes JC, Bruscato AM, Walz R, et al. Opsoclonus-myoclonus syndrome associated with Mycoplasma pneumoniae infection in an elderly patient. J Neurol Sci 2011; 305:147–148. [95]

▪▪. Otero-Millan J, Macknik SL, Serra A, et al. Triggering mechanisms in microsaccade and saccade generation: a novel proposal. Ann N Y Acad Sci 2011; 1233:107–116. [36]

▪▪. Otero-Millan J, Serra A, Leigh RJ, et al. Distinctive features of saccadic intrusions and microsaccades in progressive supranuclear palsy. J Neurosci 2011; 31:4379–4387. [03]

▪▪. Pranzatelli MR, Slev PR, Tate ED, et al. Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus. Pediatr Neurol 2011; 45:27–33. [67]

▪▪. Pranzatelli MR, Tate ED, McGee NR, et al. Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS. J Neuroimmunol 243(1–2)2012:81–88. [68]

▪. Pranzatelli MR, Tate ED, Shenoy S, et al. Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonus. Pediatr Blood Cancer 2012; 58:988–991. [93]

▪▪. Shaikh AG, Xu-Wilson M, Grill S, et al. ‘Staircase’ square-wave jerks in early Parkinson's disease. Br J Ophthalmol 2011; 95:705–709. [08]

▪▪. Shaikh AG, Zee DS, Optican LM, et al. The effects of ion channel blockers validate the conductance-based model of saccadic oscillations. Ann N Y Acad Sci 2011; 1233:58–63. [89]

▪. Smith JH, Dhamija R, Moseley BD, et al. N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis. Arch Neurol 2011; 68:1069–1072. [94]

▪▪. Tate ED, Pranzatelli MR, Verhulst SJ, et al. Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome. J Child Neurol 2012; 27:875–884. [90]

▪. Tilikete C, Jasse L, Vukusic S, et al. Persistent ocular motor manifestations and related visual consequences in multiple sclerosis. Ann N Y Acad Sci 2011; 1233:327–334. [41]

▪. Yonekawa T, Saito Y, Sakuma H, et al. Augmented startle responses in opsoclonus-myoclonus syndrome. Brain Dev 2011; 33:335–338. [78]

Oculopalatal tremor: current concepts and new observations

Review: (pp. 67–73)

Bassani R, Mariotti C, Nanetti L, Grisoli M, et al. Pendular nystagmus in progressive ataxia and palatal tremor. J Neurol 2011; 258:1877–1879.

Carota A, Duron N, Cereda C, Bassetti CL. Vertical pendular nystagmus and hypertrophic inferior olivary nuclei degeneration: an ‘‘odd couple’'. J Neurol 2012; 259:372–374.

▪. Dinçer A, Özyurt O, Kaya D, et al. Diffusion tensor imaging of Guillain-Mollaret triangle in patients with hypertrophic olivary degeneration. J Neuroimaging 2011; 21:145–151. [42]

▪. Jang SH, Chang PH, Kwon HG. The neural connectivity of the inferior olivary nucleus in the human brain: a diffusion tensor tractography study. Neurosci Lett 2012; 523:67–70. [45]

Kiernan DF, Zelkha R, Hariprasad SM, Lim JI, et al. En face spectral-domain optical coherence tomography outer retinal analysis and relation to visual acuity. Retin-J Retin Vitr Dis 2012; 32:1077–1086.

▪. Kumar N, Eggers SDZ, Milone M, Keegan BM. Acquired progressive ataxia and palatal tremor: importance of MRI evidence of hemosiderin deposition and vascular malformations. Parkinson Rel Dis 2011; 17:565–568. [25]

Kumar N, Eggers SDZ, Milone M, Keegan BM. Acquired progressive ataxia and palatal tremor: Importance of MRI evidence of hemosiderin deposition and vascular malformations. Parkinsonism Relat Disord 2011; 17:565–568.

Lopez JL, Zee DS, Levi L. Eye closure and oculopalatal tremor. Neurology 2011; 77:1929.

Margari F, Giannella G, Lecce PA, Fanizzi P, et al. A childhood case of symptomatic essential and psychogenic palatal tremor. Neuropsychiatr Dis Treat 2011; 7:223–227.

▪. Park YG, Park HY, Lee CJ, et al. Cav3.1 is a tremor rhythm pacemaker in the inferior olive. Proc Natl Acad Sci U S A 2010; 107:10731–10736. [49]

▪. Rekling JC, Jensen KHR, Jahnsen H. Spontaneous cluster activity in the inferior olivary nucleus in brainstem slices from postnatal mice. J Physiol 2012; 590:1547–1562. [48]

▪. Sanverdi SE, Oguz KK, Haliloglu G. Hypertrophic olivary degeneration in children: four new cases and a review of the literature with an emphasis on the MRI findings. Br J Radiol 2012; 85:511–516. [08]

▪▪. Shaikh AG, Hong S, Liao K, et al. Oculopalatal tremor explained by a model of inferior olivary hypertrophy and cerebellar plasticity. Brain 2010; 133:923–940. [50]

▪. Shaikh AG, Thurtell MJ, Optican LM, Leigh RJ. Pharmacological tests of hypotheses for acquired pendular nystagmus. Ann N Y Acad Sci 2011; 1233:320–326. [55]

▪. Tarnutzer AA, Palla A, Marti S, et al. Hypertrophy of the inferior olivary nucleus impacts perception of gravity. Front Neurol 2012; 3:79. [53]

▪. Thurtell MJ, Leigh RJ. Treatment of nystagmus. Curr Treat Opt Neurol 2012; 14:60–72. [56]

▪▪. Tilikete C, Jasse L, Pelisson D, et al. Acquired pendular nystagmus in multiple sclerosis and oculopalatal tremor. Neurology 2011; 76:1650–1657. [18]

▪. Torben-Nielsen B, Segev I, Yarom Y. The generation of phase differences and frequency changes in a network model of inferior olive subthreshold oscillations. PLoS Comput Biol 2012; 8:e1002580. [51]

▪. Vossough A, Ziai P, Chatzkel JA. Red nucleus degeneration in hypertrophic olivary degeneration after pediatric posterior fossa tumor resection: use of susceptibility-weighted imaging (SWI). Pediatr Radiol 2012; 42:481–485. [46]

New perspectives on vestibular evoked myogenic potentials

Review: (pp. 74–80)

▪. Govender S, Rosengren SM, Colebatch JG. Vestibular neuritis has selective effects on air- and bone-conducted cervical and ocular vestibular evoked myogenic potentials. Clin Neurophysiol 2011; 122:1246–1255. [22]

▪. Holmeslet B, Westin M, Brantberg K. Ocular vestibular evoked myogenic potentials: skull taps can cause a stimulus direction dependent double-peak. Clin Neurophysiol 2011; 122:391–397. [61]

Huang CH, Wang SJ, Young YH. Correlation between caloric and ocular vestibular evoked myogenic potential test results. Acta Oto-Laryngologica 2012; 132:160–166.

▪. Manzari L, Burgess AM, McGarvie LA, Curthoys IS. Ocular and cervical vestibular-evoked myogenic potentials to 500 Hz Fz bone-conducted vibration in superior semicircular canal dehiscence. Ear Hear 2012; 33:508–520. [44]

Murofushi T, Nakahara H, Yoshimura E, Tsuda Y. Association of air-conducted sound oVEMP findings with cVEMP and caloric test findings in patients with unilateral peripheral vestibular disorders. Acta Oto-Laryngologica 2011; 131:945–950.

▪▪. Shin B-S, Oh S-Y, Kim JS, et al. Cervical and ocular vestibular-evoked myogenic potentials in acute vestibular neuritis. Clin Neurophysiol 2012; 123:369–375. [23]

▪. Taylor RL, Bradshaw AP, Halmagyi GM, Welgampola MS. Tuning characteristics of ocular and cervical vestibular evoked myogenic potentials in intact and dehiscent ears. Audiol Neurotol 2012; 17:207–218. [43]

▪▪. Uchino Y, Kushiro K. Differences between otolith- and semicircular canal-activated neural circuitry in the vestibular system. Neurosci Res 2011; 71:315–327. [37]

▪. Weber KP, Rosengren SM, Michels R, et al. Single motor unit activity in human extraocular muscles during the vestibulo-ocular reflex. J Physiol 2012; 590:3091–3101. [08]

▪. Winters SM, Campschroer T, Grolman W, Klis SFL. Ocular vestibular evoked myogenic potentials in response to air-conducted sound in Ménière's disease. Otol Neurotol 2011; 32:1273–1280. [58]

▪. Zhang AS, Govender S, Colebatch JG. Tuning of the ocular vestibular evoked myogenic potential to bone-conducted sound stimulation. J App Physiol 2012; 112:1279–1290. [50]

Peripheral vestibular disorders

Review: (pp. 81–89)

▪. Brandt T, Dieterich M, Strupp M. Vertigo and dizziness – common complaints. 2nd ed. London: Springer; 2013. [01]

▪. Casani AP, Piaggi P, Cerchiai N, et al. Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Head Neck Surg 2012; 146:430–437. [66]

Cohen HS, Sangi-Haghpeykar H. Subjective visual vertical in vestibular disorders measured with the bucket test. Acta Oto-Laryngologica 2012; 132:850–854.

Dickson S. Vestibular Disorders: A Case-study Approach to Diagnosis and Treatment, 3rd edition. Clin Neuropsychol 2011; 25:846–848.

▪. Guinand N, Pijnenburg M, Janssen M, Kingma H. Visual acuity while walking and oscillopsia severity in healthy subjects and patients with unilateral and bilateral vestibular function loss. Arch Otolaryngol Head Neck Surg 2012; 138:301–306. [08]

▪▪. Ihler F, Bertlich M, Sharaf K, et al. Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in Guinea pigs in vivo. PLoS One 2012; 7:e39086. [69]

▪. Kim JS, Oh SY, Lee SH, et al. Randomized clinical trial for geotropic horizontal canal benign paroxysmal positional vertigo. Neurology 2012; 79:700–707. [47]

▪. Radtke A, von Brevern M, Neuhauser H, et al. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology 2012; 79:1607–1614. [43]

▪. Strupp M, Stuckrad-Barre S, Brandt T, Tonn JC. Compression of the eighth cranial nerve causes vestibular paroxysmia. Neurology (in press). [82]

▪▪. Szmulewicz DJ, Waterston JA, Halmagyi GM, et al. Sensory neuropathy as part of the cerebellar ataxia neuropathy vestibular areflexia syndrome. Neurology 2011; 76:1903–1910. [10]

▪▪. Van de Berg R, Guinand N, Guyot JP, et al. The modified ampullar approach for vestibular implant surgery: feasibility and its first application in a human with a long-term vestibular loss. Front Neurol 2012; 3:18. [15]

▪. Von-Brevern M, Bertholon P, Fife T, et al. Benign paroxysmal positional vertigo – diagnostic criteria. J Vestib Res (in press). [41]

Vertigo in brainstem and cerebellar strokes

Review: (pp. 90–95)

▪. Baier B, Dieterich M. Incidence and anatomy of gaze-evoked nystagmus in patients with cerebellar lesions. Neurology 2011; 76:361–365. [48]

▪. Chandrakumar M, Blakeman A, Goltz HC, et al. Static ocular counterroll reflex in skew deviation. Neurology 2011; 77:638–644. [40]

Chou CI, Lin HC, Wu KC, Shu MT. Brainstem hemorrhage presented as audiovestibular syndromes. Am J Otolaryngol 2012; 33:356–357.

▪▪. Huh YE, Kim JS. Patterns of spontaneous and head-shaking nystagmus in cerebellar infarction: imaging correlations. Brain 2011; 134:3662–3671. [49]

Huh YE, Kim JS. Patterns of spontaneous and head-shaking nystagmus in cerebellar infarction: imaging correlations. Brain 2011; 134:3659–3668.

Ikegami-Takada T, Izumikawa M, Doi T, Takada Y, et al. AICA syndrome with facial palsy following vertigo and acute sensorineural hearing loss. Auris, Nasus, Larynx 2012; 39:244–248.

▪▪. Jeong SH, Kim EK, Lee J, et al. Patterns of dissociate torsional-vertical nystagmus in internuclear ophthalmoplegia. Ann N Y Acad Sci 2011; 1233:271–278. [32]

▪▪. Lee CC, Su YC, Ho HC, et al. Risk of stroke in patients hospitalized for isolated vertigo: a four-year follow-up study. Stroke 2011; 42:48–52. [09]

▪. Lee H. Audiovestibular loss in anterior inferior cerebellar artery territory infarction: a window to early detection? J Neurol Sci 2012; 313:153–159. [47]

▪. Navi BB, Kamel H, Shah MP, et al. Application of the ABCD2 score to identify cerebrovascular causes of dizziness in the emergency department. Stroke 2012; 43:1484–1489. [11]

Navi BB, Kamel H, Shah MP, Grossman AW, et al. Application of the ABCD(2) Score to Identify Cerebrovascular Causes of Dizziness in the Emergency Department. Stroke 2012; 43:1484–1489.

▪. Noh Y, Kwon OK, Kim HJ, et al. Rotational vertebral artery syndrome due to compression of nondominant vertebral artery terminating in posterior inferior cerebellar artery. J Neurol 2011; 258:1775–1780. [24]

Noh Y, Kwon OK, Kim HJ, Kim JS. Rotational vertebral artery syndrome due to compression of nondominant vertebral artery terminating in posterior inferior cerebellar artery. J Neurol 2011; 258:1775–1780.

▪. Oh SY, Kim JS, Lee JM, et al. Ocular vestibular evoked myogenic potentials induced by air-conducted sound in patients with acute brainstem lesions. Clin Neurophysiol 2012; doi:10.1016/j.clinph.2012.09.026. [Epub ahead of print] [39]

Ohki M, Tanaka K. An Isolated Vestibulocochlear Symptom Preceding Brainstem Infarction Due to Basilar Artery Occlusion. Otol Neurotol 2012; 33:730–732.

▪▪. Tarnutzer AA, Berkowitz AL, Robinson KA, et al. Does my dizzy patient have a stroke? A systematic review of bedside diagnosis in acute vestibular syndrome. CMAJ 2011; 183:E571–E592. [12]

▪▪. Tilikete C, Jasse L, Pelisson D, et al. Acquired pendular nystagmus in multiple sclerosis and oculopalatal tremor. Neurology 2011; 76:1650–1657. [31]

Vestibular rehabilitation

Review: (pp. 96–101)

▪▪. Chen Y, Zhuang J, Zhang L, et al. Short-term efficacy of Semont maneuver for benign paroxysmal positional vertigo: a double-blind randomized trial. Otol Neurotol 2012; 33:1127–1130. [25]

Cohen HS. Assessment of functional outcomes in patients with vestibular disorders after rehabilitation. Neurorehabilitation 2011; 29:173–178.

Gottshall K. Vestibular rehabilitation after mild traumatic brain injury with vestibular pathology. Neurorehabilitation 2011; 29:167–171.

▪▪. Herdman SJ, Hall CD, De laune W. Variables associated with outcome in patients with unilateral vestibular hypofunction. Neurorehabil Neural Repair 2012; 26:151–162. [13]

Jahn K, Dieterich M. Recent advances in the diagnosis and treatment of balance disorders. J Neurol 2011; 258:2305–2308.

▪. Kerber KA, Burke JF, Skolarus LE, et al. A prescription for the Epley maneuver: http://www.youtube.com? Neurology 2012; 79:376–380. [30]

Magnusson M, Karlberg M, Tjernstrom F. 'PREHAB': Vestibular prehabilitation to ameliorate the effect of a sudden vestibular loss. Neurorehabilitation 2011; 29:153–156.

▪▪. Mandalà M, Santoro GP, Asprella Libonati C, et al. Double-blind randomized trial on short-term efficacy of the Semont maneuver for the treatment of posterior canal benign paroxysmal positional vertigo. J Neurol 2012; 259:882–885. [24]

Rossi-Izquierdo M, Santos-Perez S, Soto-Varela A. What is the most effective vestibular rehabilitation technique in patients with unilateral peripheral vestibular disorders? Eur Arch Oto-Rhino-Laryn 2011; 268:1569–1574.

Slattery EL, Sinks BC, Goebel JA. Vestibular tests for rehabilitation: Applications and interpretation. Neurorehabilitation 2011; 29:143–151.

Staab JP. Behavioral aspects of vestibular rehabilitation. Neurorehabilitation 2011; 29:179–183.

Optical Coherence Tomography of the Retinal Layers: Diagnoses of Visual Loss Beyond the Retinal Nerve Fibre Layer

Al-Haddad CE, Mollayess G, Cherfan CG, Jaafar DF, et al. Retinal nerve fibre layer and macular thickness in amblyopia as measured by spectral-domain optical coherence tomography. Br J Ophthalmol 2011; 95:1696–1699.

Anastasakis A, Genead MA, McAnany JJ, Fishman GA. Evaluation of retinal nerve fiber layer thickness in patients with retinitis pigmentosa using spectral-domain optical coherence tomography. Retin-J Retin Vitr Dis 2012; 32:358–363.

Balk LJ, Sonder JM, Strijbis EMM, Twisk JWR, et al. The Physiological Variation of the Retinal Nerve Fiber Layer Thickness and Macular Volume in Humans as Assessed by Spectral Domain-Optical Coherence Tomography. Invest Ophthalmol Vis Sci 2012; 53:1251–1257.

Barboni P, Savini G, Parisi V, Carbonelli M, et al. Retinal Nerve Fiber Layer Thickness in Dominant Optic Atrophy Measurements by Optical Coherence Tomography and Correlation with Age. Ophthalmology 2011; 118:2076–2080.

Byeon SH, Chu YK, Hong YT, Kim M, et al. NEW INSIGHTS INTO THE PATHOANATOMY OF DIABETIC MACULAR EDEMA Angiographic Patterns and Optical Coherence Tomography. Retin-J Retin Vitr Dis 2012; 32:1087–1099.

Cho HJ, Lee DW, Kim CG, Kim JW. Spectral domain optical coherence tomography findings in acute retinal pigment epitheliitis. Can J Opthalmol-J Can Opthalmol 2011; 46:498–500.

Clark ME, McGwin G, Neely D, Feist R, et al. Association between retinal thickness measured by spectral-domain optical coherence tomography (OCT) and rod-mediated dark adaptation in non-exudative age-related maculopathy. Br J Ophthalmol 2011; 95:1427–1432.

Comander J, Gardiner M, Loewenstein J. High-Resolution Optical Coherence Tomography Findings in Solar Maculopathy and the Differential Diagnosis of Outer Retinal Holes. Am J Ophthalmol 2011; 152:413–419.

Dell'Omo R, Mura M, Oberstein SYL, Bijl H, et al. Early simultaneous fundus autofluorescence and optical coherence tomography features after pars plana vitrectomy for primary rhegmatogenous retinal detachment. Retin-J Retin Vitr Dis 2012; 32:719–728.

Dickmann A, Petroni S, Perrotta V, Parrilla R, et al. Measurement of retinal nerve fiber layer thickness, macular thickness, and foveal volume in amblyopic eyes using spectral-domain optical coherence tomography. J Aapos 2012; 16:86–88.

Eckstein C, Saidha S, Sotirchos ES, Byraiah G, et al. Detection of clinical and subclinical retinal abnormalities in neurosarcoidosis with optical coherence tomography. J Neurol 2012; 259:1390–1398.

Folio LS, Wollstein G, Ishikawa H, Bilonick RA, et al. Variation in optical coherence tomography signal quality as an indicator of retinal nerve fibre layer segmentation error. Br J Ophthalmol 2012; 96:514–518.

Gharbiya M, Grandinetti F, Scavella V, Cecere M, et al. Correlation between spectral-domain optical coherence tomography findings and visual outcome after primary rhegmatogenous retinal detachment repair. Retin-J Retin Vitr Dis 2012; 32:43–53.

Giani A, Peroglio A, Staurenghi G. Repeatability and reproducibility of retinal thickness measurements with spectral-domain optical coherence tomography using different scan parameters. Retin-J Retin Vitr Dis 2012; 32:1007–1012.

Goldenberg D, Habot-Wilner Z, Loewenstein A, Goldstein M. Spectral domain optical coherence tomography classification of acute posterior multifocal placoid pigment epitheliopathy. Retin-J Retin Vitr Dis 2012; 32:1403–1410.

Golzan SM, Avolio A, Graham SL. Minimising retinal vessel artefacts in optical coherence tomography images. Comput Meth Programs Biomed 2011; 104:206–211.

Grewal DS, Sehi M, Paauw JD, Greenfield DS. Detection of Progressive Retinal Nerve Fiber Layer Thickness Loss With Optical Coherence Tomography Using 4 Criteria for Functional Progression. J Glaucoma 2012; 21:214–220.

Grieshaber MC, Moramarco F, Schoetzau A, Flammer J, et al. Detection of Retinal Glial Cell Activation in Glaucoma by Time Domain Optical Coherence Tomography. Klinische Monatsblat Augenheilkunde 2012; 229:314–318.

Hariri S, Moayed AA, Choh V, Bizheva K. In Vivo Assessment of Thickness and Reflectivity in a Rat Outer Retinal Degeneration Model with Ultrahigh Resolution Optical Coherence Tomography. Invest Ophthalmol Vis Sci 2012; 53:1982–1989.

Hayashi K, Tomidokoro A, Lee KYC, Konno S, et al. Spectral-Domain Optical Coherence Tomography of beta-zone Peripapillary Atrophy: Influence of Myopia and Glaucoma. Invest Ophthalmol Vis Sci 2012; 53:1499–1505.

Hein K, Gadjanski I, Kretzschmar B, Lange K, et al. An Optical Coherence Tomography Study on Degeneration of Retinal Nerve Fiber Layer in Rats with Autoimmune Optic Neuritis. Invest Ophthalmol Vis Sci 2012; 53:157–163.

Hoffmann EM. Optical Coherence Tomography (OCT) in Glaucoma Diagnostics. Klinische Monatsblat Augenheilkunde 2012; 229:135–142.

Hood DC, Zhang X, Ramachandran R, Talamini CL, et al. The Inner Segment/Outer Segment Border Seen on Optical Coherence Tomography Is Less Intense in Patients with Diminished Cone Function. Invest Ophthalmol Vis Sci 2011; 52:9703–9709.

Hsu SY, Ko ML, Linn G, Chang MS, et al. Effects of age and disc area on optical coherence tomography measurements and analysis of correlations between optic nerve head and retinal nerve fibre layer. Clin Exp Optom 2012; 95:427–431.

Huang JJ, Liu X, Wu ZQ, Sadda S. Image Quality Affects Macular and Retinal Nerve Fiber Layer Thickness Measurements on Fourier-Domain Optical Coherence Tomography. Ophthalmic Surg Lasers Imaging 2011; 42:216–221.

Huang YJ, Gangaputra S, Lee KE, Narkar AR, et al. Signal Quality Assessment of Retinal Optical Coherence Tomography Images. Invest Ophthalmol Vis Sci 2012; 53:2133–2141.

Hwang YH, Lee JY, Kim YY. The effect of head tilt on the measurements of retinal nerve fibre layer and macular thickness by spectral-domain optical coherence tomography. Br J Ophthalmol 2011; 95:1547–1551.

Hwang YH, Yoo C, Kim YY. Myopic Optic Disc Tilt and the Characteristics of Peripapillary Retinal Nerve Fiber Layer Thickness Measured by Spectral-domain Optical Coherence Tomography. J Glaucoma 2012; 21:260–265.

Kahn JB, Haberman ID, Reddy S. Spectral-Domain Optical Coherence Tomography as a Screening Technique for Chloroquine and Hydroxychloroquine Retinal Toxicity. Ophthalmic Surg Lasers Imaging 2011; 42:493–497.

Kanamori A, Nakamura M, Tabuchi K, Yamada Y, et al. Effects of ocular rotation on parapapillary retinal nerve fiber layer thickness analysis measured with spectral-domain optical coherence tomography. Jpn J Ophthalmol 2012; 56:354–361.

Kara N, Altinkaynak H, Yuksel K, Kurt T, et al. Effects of posterior capsular opacification on the evaluation of retinal nerve fiber layer as measured by stratus optical coherence tomography. Can J Opthalmol-J Can Opthalmol 2012; 47:176–180.

Kardon RH. Role of the Macular Optical Coherence Tomography Scan in Neuro-Ophthalmology. J Neuro-Ophthal 2011; 31:353–361.

Kaushik S, Pandav SS, Ichhpujani P, Gupta A, et al. Retinal nerve fiber layer measurement and diagnostic capability of spectral-domain versus time-domain optical coherence tomography. Eur J Ophthalmol 2011; 21:566–572.

Khan S, Engelbert M, Imamura Y, Freund KB. POLYPOIDAL CHOROIDAL VASCULOPATHY Simultaneous Indocyanine Green Angiography and Eye-Tracked Spectral Domain Optical Coherence Tomography Findings. Retin-J Retin Vitr Dis 2012; 32:1057–1068.

Kiernan DF, Zelkha R, Hariprasad SM, Lim JI, et al. En face spectral-domain optical coherence tomography outer retinal analysis and relation to visual acuity. Retin-J Retin Vitr Dis 2012; 32:1077–1086.

Kim DY, Fingler J, Zawadzki RJ, Park SS, et al. Noninvasive Imaging of the Foveal Avascular Zone with High-Speed, Phase-Variance Optical Coherence Tomography. Invest Ophthalmol Vis Sci 2012; 53:85–92.

Kim JH, Kim NR, Lee ES, Rho S, et al. Influence of Blue Light-filtering Intraocular Lenses on Retinal Nerve Fiber Layer Measurements by Spectral-domain Optical Coherence Tomography. Curr Eye Res 2011; 36:937–942.

Kim NR, Lee H, Lee ES, Kim JH, et al. Influence of Cataract on Time Domain and Spectral Domain Optical Coherence Tomography Retinal Nerve Fiber Layer Measurements. J Glaucoma 2012; 21:116–122.

Kim NR, Lim H, Kim JH, Rho SS, et al. Factors Associated with False Positives in Retinal Nerve Fiber Layer Color Codes from Spectral-Domain Optical Coherence Tomography. Ophthalmology 2011; 118:1774–1781.

Koo HC, Rhim WI, Lee EK. Morphologic and functional association of retinal layers beneath the epiretinal membrane with spectral-domain optical coherence tomography in eyes without photoreceptor abnormality. Graefes Arch Clin Exp Ophthalmol 2012; 250:491–498.

Krebs I, Hagen S, Smretschnig E, Womastek I, et al. Conversion of Stratus optical coherence tomography (OCT) retinal thickness to Cirrus OCT values in age-related macular degeneration. Br J Ophthalmol 2011; 95:1552–1554.

Kupersmith MJ, Sibony P, Mandel G, Durbin M, et al. Optical Coherence Tomography of the Swollen Optic Nerve Head: Deformation of the Peripapillary Retinal Pigment Epithelium Layer in Papilledema. Invest Ophthalmol Vis Sci 2011; 52:6558–6564.

Lazow MA, Hood DC, Ramachandran R, Burke TR, et al. Transition Zones between Healthy and Diseased Retina in Choroideremia (CHM) and Stargardt Disease (STGD) as Compared to Retinitis Pigmentosa (RP). Invest Ophthalmol Vis Sci 2011; 52:9581–9590.

Lee EK, Woo SJ, Ahn J, Park KH. Morphologic characteristics of retinal arterial macroaneurysm and its regression pattern on spectral-domain optical coherence tomography. Retin-J Retin Vitr Dis 2011; 31:2095–2101.

Lee J, Kim NR, Kim H, Han J, et al. Negative refraction power causes underestimation of peripapillary retinal nerve fibre layer thickness in spectral-domain optical coherence tomography. Br J Ophthalmol 2011; 95:1284–1289.

Lee S, Sheck L, Crowston JG, Van Bergen NJ, et al. Impaired Complex-I-Linked Respiration and ATP Synthesis in Primary Open-Angle Glaucoma Patient Lymphoblasts. Invest Ophthalmol Vis Sci 2012; 53:2431–2437.

Lenassi E, Troeger E, Wilke R, Hawlina M. Correlation between Macular Morphology and Sensitivity in Patients with Retinitis Pigmentosa and Hyperautofluorescent Ring. Invest Ophthalmol Vis Sci 2012; 53:47–52.

Leung CKS, Yu M, Weinreb RN, Ye C, et al. Retinal Nerve Fiber Layer Imaging with Spectral-Domain Optical Coherence Tomography A Prospective Analysis of Age-Related Loss. Ophthalmology 2012; 119:731–737.

Lopez-Pena MJ, Ferreras A, Larrosa JM, Polo V, et al. Relationship Between Standard Automated Perimetry and Retinal Nerve Fiber Layer Parameters Obtained With Optical Coherence Tomography. J Glaucoma 2011; 20:422–432.

Maldonado RS, O'Connell R, Ascher SB, Sarin N, et al. Spectral-Domain Optical Coherence Tomographic Assessment of Severity of Cystoid Macular Edema in Retinopathy of Prematurity. Arch Ophthalmol 2012; 130:569–578.

Maldonado RS, O'Connell RV, Sarin N, Freedman SF, et al. Dynamics of Human Foveal Development after Premature Birth. Ophthalmology 2011; 118:2315–2325.

Moayed AA, Hariri S, Choh V, Bizheva K. Correlation of visually evoked intrinsic optical signals and electroretinograms recorded from chicken retina with a combined functional optical coherence tomography and electroretinography system - art. no. 016011. J Biomed Opt 2012; 17:16011.

Monteiro MLR, Fernandes DB, Apostolos-Pereira SL, Callegaro D. Quantification of Retinal Neural Loss in Patients with Neuromyelitis Optica and Multiple Sclerosis with or without Optic Neuritis Using Fourier-Domain Optical Coherence Tomography. Invest Ophthalmol Vis Sci 2012; 53:3959–3966.

Moreno-Montanes J, Anton A, Olmo N, Bonet E, et al. Misalignments in the Retinal Nerve Fiber Layer Evaluation Using Cirrus High-definition Optical Coherence Tomography. J Glaucoma 2011; 20:559–565.

Moreno PAM, Konno B, Lima VC, Castro DPE, et al. Spectral-domain optical coherence tomography for early glaucoma assessment: analysis of macular ganglion cell complex versus peripapillary retinal nerve fiber layer. Can J Opthalmol-J Can Opthalmol 2011; 46:543–547.

Motaghiannezam R, Schwartz DM, Fraser SE. In Vivo Human Choroidal Vascular Pattern Visualization Using High-Speed Swept-Source Optical Coherence Tomography at 1060 nm. Invest Ophthalmol Vis Sci 2012; 53:2337–2348.

Motaghiannezam SMR, Koos D, Fraser SE. Differential phase-contrast, swept-source optical coherence tomography at 1060 nm for in vivo human retinal and choroidal vasculature visualization - art. no. 026011. J Biomed Opt 2012; 17:26011.

Mwanza JC, Oakley JD, Budenz DL, Chang RT, et al. Macular Ganglion Cell-Inner Plexiform Layer: Automated Detection and Thickness Reproducibility with Spectral Domain-Optical Coherence Tomography in Glaucoma. Invest Ophthalmol Vis Sci 2011; 52:8323–8329.

Na JH, Sung KR, Baek S, Kim YJ, et al. Detection of Glaucoma Progression by Assessment of Segmented Macular Thickness Data Obtained Using Spectral Domain Optical Coherence Tomography. Invest Ophthalmol Vis Sci 2012; 53:3817–3826.

Nagy ZZ, Ecsedy M, Kovacs I, Takacs A, et al. Macular morphology assessed by optical coherence tomography image segmentation after femtosecond laser-assisted and standard cataract surgery. J Cataract Refract Surg 2012; 38:941–946.

Nakano N, Hangai M, Nakanishi H, Mori S, et al. Macular Ganglion Cell Layer Imaging in Preperimetric Glaucoma with Speckle Noise-Reduced Spectral Domain Optical Coherence Tomography. Ophthalmology 2011; 118:2414–2426.

Park KA, Park DY, Oh SY. Analysis of spectral-domain optical coherence tomography measurements in amblyopia: a pilot study. Br J Ophthalmol 2011; 95:1700–1706.

Penha FM, Rosenfeld PJ, Gregori G, Falcao M, et al. Quantitative Imaging of Retinal Pigment Epithelial Detachments Using Spectral-Domain Optical Coherence Tomography. Am J Ophthalmol 2012; 153:515–523.

Qian J, Wang WJ, Zhang X, Wang FH, et al. Optical Coherence Tomography Measurements of Retinal Nerve Fiber Layer Thickness in Chinese Children and Teenagers. J Glaucoma 2011; 20:509–513.

Qiu KL, Zhang MZ, Leung CKS, Zhang RP, et al. Diagnostic Classification of Retinal Nerve Fiber Layer Measurement in Myopic Eyes: A Comparison Between Time-Domain and Spectral-Domain Optical Coherence Tomography. Am J Ophthalmol 2011; 152:646–653.

Querques G, Avellis FO, Querques L, Massamba N, et al. Three dimensional spectral domain optical coherence tomography features of retinal-choroidal anastomosis. Graefes Arch Clin Exp Ophthalmol 2012; 250:165–173.

Querques G, Canoui-Poitrine F, Coscas F, Massamba N, et al. Analysis of Progression of Reticular Pseudodrusen by Spectral Domain-Optical Coherence Tomography. Invest Ophthalmol Vis Sci 2012; 53:1264–1270.

Ray R, Baranano DE, Fortun JA, Schwent BJ, et al. Intraoperative Microscope-Mounted Spectral Domain Optical Coherence Tomography for Evaluation of Retinal Anatomy during Macular Surgery Robin. Ophthalmology 2011; 118:2212–2217.

Saidha S, Syc SB, Durbin MK, Eckstein C, et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler J 2011; 17: 1449–1463.

Salih P. Evaluation of Peripapillary Retinal Nerve Fiber Layer Thickness in Myopic Eyes by Spectral-domain Optical Coherence Tomography. J Glaucoma 2012; 21:41–44.

Sarda V, Nakashima K, Wolff B, Sahel JA, et al. Topography of patchy retinal whitening during acute perfused retinal vein occlusion by optical coherence tomography and adaptive optics fundus imaging. Eur J Ophthalmol 2011; 21:653–656.

Sayegh RG, Simader C, Scheschy U, Montuoro A, et al. A Systematic Comparison of Spectral-Domain Optical Coherence Tomography and Fundus Autofluorescence in Patients with Geographic Atrophy. Ophthalmology 2011; 118:1844–1851.

Schrems WA, Laemmer R, Hoesl LM, Horn FK, et al. Influence of atypical retardation pattern on the peripapillary retinal nerve fibre distribution assessed by scanning laser polarimetry and optical coherence tomography. Br J Ophthalmol 2011; 95:1437–1441.

Song W, Wei Q, Liu T, Kuai D, et al. Integrating photoacoustic ophthalmoscopy with scanning laser ophthalmoscopy, optical coherence tomography, and fluorescein angiography for a multimodal retinal imaging platform - art. no. 061206. J Biomed Opt 2012; 17:61206.

Suzuma K, Yamada Y, Liu MC, Tsuiki E, et al. Comparing central retinal thickness in diabetic macular edema measured by two different spectral-domain optical coherence tomography devices. Jpn J Ophthalmol 2011; 55:620–624.

Syc SB, Saidha S, Newsome SD, Ratchford JN, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 2012; 135:521–533.

Tsai DC, Huang N, Hwu JJ, Jueng RN, et al. Estimating retinal nerve fiber layer thickness in normal schoolchildren with spectral-domain optical coherence tomography. Jpn J Ophthalmol 2012; 56:362–370.

van der Schoot J, Vermeer KA, de Boer JF, Lemij HG. The Effect of Glaucoma on the Optical Attenuation Coefficient of the Retinal Nerve Fiber Layer in Spectral Domain Optical Coherence Tomography Images. Invest Ophthalmol Vis Sci 2012; 53:2424–2430.

Wang YH, Jiang H, Shen MX, Lam BL, et al. Quantitative analysis of the intraretinal layers and optic nerve head using ultra-high resolution optical coherence tomography - art. no. 066013. J Biomed Opt 2012; 17:66013.

Wasyluk JT, Jankowska-Lech I, Terelak-Borys B, Grabska-Liberek I. Comparative study of the retinal nerve fibre layer thickness performed with optical coherence tomography and GDx scanning laser polarimetry in patients with primary open-angle glaucoma. Med Sci Monitor 2012; 18:CR195–CR199.

Wong R. Longitudinal Study of Macular Folds by Spectral-Domain Optical Coherence Tomography. Am J Ophthalmol 2012; 153:88–92.

Wu HJ, de Boer JF, Chen TC. Reproducibility of Retinal Nerve Fiber Layer Thickness Measurements Using Spectral Domain Optical Coherence Tomography. J Glaucoma 2011; 20:470–476.

Wu XS, Xu L, Jonas JB, Zhang L, et al. Agreement Between Spectral Domain Optical Coherence Tomography and Retinal Nerve Fiber Layer Photography in Chinese. J Glaucoma 2012; 21:228–233.

Ye C, Lam DS, Leung CKS. Retinal Nerve Fiber Layer Imaging With Spectral-domain Optical Coherence Tomography: Effect of Multiple B-Scan Averaging on RNFL Measurement. J Glaucoma 2012; 21:164–168.

Yousef YA, Finger PT. Optical Coherence Tomography of Radiation Optic Neuropathy. Ophthalmic Surg Lasers Imaging 2012; 43:6–12.

Zhou YD, Sheets KG, Knott EJ, Regan CE, et al. Cellular and 3D optical coherence tomography assessment during the initiation and progression of retinal degeneration in the Ccl2/Cx3cr1-deficient mouse. Exp Eye Res 2011; 93:636–648.

Downbeatnystagmus

Attias J, Nageris BI, Shemesh R, Shvero J, et al. Superior Canal Dehiscence Effect on Hearing Thresholds: Animal Model. Otolaryngology - Head & Neck Surgery 2011; 145:648–653.

Rossi-Izquierdo M, Santos-Perez S, Soto-Varela A. What is the most effective vestibular rehabilitation technique in patients with unilateral peripheral vestibular disorders? Eur Arch Oto-Rhino-Laryn 2011; 268:1569–1574.

Wang SY, Peng Q, Zhao PQ. SD-OCT Use in Myopic Retinoschisis Pre- and Post-Vitrectomy. Optom Vis Sci 2012; 89:678–683.

© 2013 Lippincott Williams & Wilkins, Inc.